UnknownNCT03014934

Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation

Studying Aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
European Society for Blood and Marrow Transplantation
Principal Investigator
Olaf Penack, MD
Charite University, Berlin, Germany
Enrollment
2100 enrolled
Eligibility
All sexes
Timeline
20162021

Study locations (8)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03014934 on ClinicalTrials.gov

Other trials for Aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Aspergillosis

← Back to all trials